Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Lurasidonum
 |
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
| Cognitores | |
|---|---|
| ChemSpider | 184739 |
| PubChem | 213046 |
| DrugBank | DB08815 |
| Natura chemica | |
| |
| |
| Formula chemica | C 28H 36N 4O 2S |
| Massa molaris | 492.68 g/mol |
| Natura pharmacologica | |
| Codex ATC | N05AE05 (WHO) |
| Semivita biologica | 18-40 h |
| Metabolismus | iecore (hepaticus): CYP3A4 |
| Excretio | faecibus 67-80% renibus 9-19% |
| Ad usum therapeuticum | |
| Applicatio | per os |
| DDD | 60 mg (•HCl) |
| MedlinePlus | a611016 (Anglice) |
Lurasidonum est medicamentum pharmaceuticum et antipsychoticum atypicum ad schizophreniam et ad conturbationem bipolarem[1] tractandam.
Lurasidonum imprimis receptoria D2 et 5HT-2A obsidet. Excretio Lurasidoni maiore in parte per biles et faecibus fit.
- ↑ Ketter T. A., Sarma K. (Mai 2016). "Lurasidone in the long-term treatment of patients with bipolar disorder: a 24-week open-label extension study". Depression and anxiety 33 (5): 424-34
Previous Page Next Page
